Lamotrigine Pregnancy Registry (LAM05)
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Lamotrigine (Primary) ; Antiepileptic drugs; Valproic acid
- Indications Bipolar disorders; Epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2010 Planned end date changed from 1 Jul 2015 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 22 Nov 2010 Planned End Date changed from 1 Jan 2015 to 1 Jul 2015.